Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Social jetlag: misalignment of biological and social time.

Authors:
Marc Wittmann Jenny Dinich Martha Merrow Till Roenneberg

Chronobiol Int 2006 ;23(1-2):497-509

Generation Research Program, Human Science Center, Ludwig-Maximilian University Munich, Germany.

Humans show large differences in the preferred timing of their sleep and activity. This so-called "chronotype" is largely regulated by the circadian clock. Both genetic variations in clock genes and environmental influences contribute to the distribution of chronotypes in a given population, ranging from extreme early types to extreme late types with the majority falling between these extremes. Social (e.g., school and work) schedules interfere considerably with individual sleep preferences in the majority of the population. Late chronotypes show the largest differences in sleep timing between work and free days leading to a considerable sleep debt on work days, for which they compensate on free days. The discrepancy between work and free days, between social and biological time, can be described as 'social jetlag.' Here, we explore how sleep quality and psychological wellbeing are associated with individual chronotype and/or social jetlag. A total of 501 volunteers filled out the Munich ChronoType Questionnaire (MCTQ) as well as additional questionnaires on: (i) sleep quality (SF-A), (ii) current psychological wellbeing (Basler Befindlichkeitsbogen), (iii) retrospective psychological wellbeing over the past week (POMS), and (iv) consumption of stimulants (e.g., caffeine, nicotine, and alcohol). Associations of chronotype, wellbeing, and stimulant consumption are strongest in teenagers and young adults up to age 25 yrs. The most striking correlation exists between chronotype and smoking, which is significantly higher in late chronotypes of all ages (except for those in retirement). We show these correlations are most probably a consequence of social jetlag, i.e., the discrepancies between social and biological timing rather than a simple association to different chronotypes. Our results strongly suggest that work (and school) schedules should be adapted to chronotype whenever possible.

Download full-text PDF

Source
http://dx.doi.org/10.1080/07420520500545979DOI Listing
August 2006

Publication Analysis

Top Keywords

free days
12
psychological wellbeing
12
social jetlag
12
work free
8
social biological
8
sleep quality
8
late chronotypes
8
social
7
sleep
6
chronotype
5
work
5
debt work
4
chronotype and/or
4
and/or social
4
jetlag total
4
total 501
4
501 volunteers
4
volunteers filled
4
filled munich
4
munich chronotype
4

Keyword Occurance

Similar Publications

Risk factors for ventilator-associated lower respiratory tract infection in COVID-19, a retrospective multicenter cohort study in Sweden.

Authors:
Gustaf Forsberg Knut Taxbro Louise Elander Håkan Hanberger Sören Berg Jonna Idh Johan Berkius Andreas Ekman Fredrik Hammarskjöld Katarina Niward Åse Östholm Balkhed

Acta Anaesthesiol Scand 2023 Sep 26. Epub 2023 Sep 26.

Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Background: Ventilator-associated lower respiratory tract infections (VA-LRTI) increase morbidity and mortality in intensive care unit (ICU) patients. Higher incidences of VA-LRTI have been reported among COVID-19 patients requiring invasive mechanical ventilation (IMV). The primary objectives of this study were to describe clinical characteristics, incidence, and risk factors comparing patients who developed VA-LRTI to patients who did not, in a cohort of Swedish ICU patients with acute hypoxemic respiratory failure due to COVID-19. Read More

View Article and Full-Text PDF
September 2023
Similar Publications

Bioinspired 3D-printed scaffold embedding DDAB-nano ZnO/nanofibrous microspheres for regenerative diabetic wound healing.

Authors:
Walaa M Metwally Salma E El-Habashy Lobna S El-Hosseiny Marwa M Essawy Hoda M Eltaher Labiba El-Khordagui

Biofabrication 2023 Sep 26. Epub 2023 Sep 26.

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, 1st El-Khartoum square, Alexandria, Alexandria, 21521, EGYPT.

There is a constant demand for novel materials/biomedical devices to accelerate the healing of hard-to-heal wounds. Herein, an innovative 3D-printed bioinspired construct was developed as an antibacterial/regenerative scaffold for diabetic wound healing. Hyaluronic/chitosan ink was used to fabricate a bilayer scaffold comprising a dense plain hydrogel layer topping an antibacterial/regenerative nanofibrous layer obtained by incorporating the hydrogel with polylactic acid nanofibrous microspheres (MS). Read More

View Article and Full-Text PDF
September 2023
Similar Publications

Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.

Authors:
Francesca Corti Maria Pia Brizzi Vito Amoroso Dario Giuffrida Francesco Panzuto Davide Campana Natalie Prinzi Massimo Milione Tommaso Cascella Carlo Spreafico Giovanni Randon Simone Oldani Rita Leporati Giulia Scotto Iolanda Pulice Benedetta Lombardi Stocchetti Luca Porcu Jorgelina Coppa Maria Di Bartolomeo Filippo de Braud Sara Pusceddu

BMC Cancer 2023 Sep 26;23(1):908. Epub 2023 Sep 26.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, ENETS Center of Excellence, Via Giacomo Venezian 1, 20133, Milan, Italy.

Background: Well-differentiated (WD) neuroendocrine tumors (NETs) are a group of rare neoplasms with limited therapeutic options. Cabozantinib is an inhibitor of multiple tyrosine kinases with a pivotal role in NET pathogenesis, including c-MET and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2). LOLA is the first prospective phase II trial aiming to assess the safety and activity of cabozantinib combined with lanreotide in WD NETs of gastroenteropancreatic (GEP), thoracic and of unknown origin. Read More

View Article and Full-Text PDF
September 2023
Similar Publications

Long Covid symptoms and diagnosis in primary care: A cohort study using structured and unstructured data in The Health Improvement Network primary care database.

Authors:
Anoop D Shah Anuradhaa Subramanian Jadene Lewis Samir Dhalla Elizabeth Ford Shamil Haroon Valerie Kuan Krishnarajah Nirantharakumar

PLoS One 2023 26;18(9):e0290583. Epub 2023 Sep 26.

Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.

Background: Long Covid is a widely recognised consequence of COVID-19 infection, but little is known about the burden of symptoms that patients present with in primary care, as these are typically recorded only in free text clinical notes.

Aims: To compare symptoms in patients with and without a history of COVID-19, and investigate symptoms associated with a Long Covid diagnosis.

Methods: We used primary care electronic health record data until the end of December 2020 from The Health Improvement Network (THIN), a Cegedim database. Read More

View Article and Full-Text PDF
September 2023
Similar Publications

Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-Small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery.

Authors:
Sarit Appel Akram Saad Damien Urban Amir Onn Ran Yosef Kremer Alon Ben-Nun Marina Perelman Efrat Ofek Rinat Yacobi Edith Michelle Marom Sameh Daher Hadas Gantz-Sorotsky Adi Rasco Zvi Symon Yaacov Richard Lawrence Jair Bar Jeffrey Goldstein

Br J Radiol 2023 Sep 26:20220763. Epub 2023 Sep 26.

Department of Radiation Oncology, Tel-Aviv Medical Center, Tel-Aviv, Israel.

Objectives: We hypothesized that driver mutations in epidermal growth factor receptor (EGFR) are associated with decreased pathologic response to neoadjuvant chemoradiation (NA-ChRT) in locally advanced non-small cell lung cancer (LA-NSCLC).

Methods: Patients with stage IIB-IIIA NSCLC treated with NA-ChRT, completion surgery, and underwent molecular profile testing were identified in a lung cancer database. Pathologic response was quantified using: (i) major pathologic response (MPR), (ii) complete pathologic response (pCR), and (iii) mean residual viable tumor cells (MRTC). Read More

View Article and Full-Text PDF
September 2023
Similar Publications
}
© 2023 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap